RxDoctor Payments DataLook up a doctor →

Daniel Gruener

Pain Medicine · Philadelphia, PANPI 1871713370

Payments from drug & device makers

$2,941,353in general payments, 2019–2025

Across 908 payments — averaging $3239.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1.9M
  • Roche TCRC, Inc.$321K
  • AbbVie$248K
  • Indivior Inc.$119K
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$82K
  • Alkermes, Inc.$81K
  • plus $180K from 20 others
$4,980in research payments, 2019–2025

Across 3 payments — averaging $1660.07 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • F. Hoffmann-la Roche AG$3K
  • Indivior Inc.$2K

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,941,353 in reported general payments places this provider in the 95th percentile of 294 pain medicine providers in Pennsylvania.

See all pain medicine providers in Pennsylvania

Other pain medicine in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →